ProQuest Investments

ProQuest Investments was a venture capital firm based in Princeton, New Jersey, with a dedicated focus on the healthcare sector. Established to finance companies across various stages, from seed to late-stage, ProQuest played a role in supporting the growth of numerous biotechnology and life sciences ventures. The firm's investment strategy centered on identifying promising innovations within pharmaceuticals, medical devices, and diagnostics, aiming to drive advancements in patient care.

Historically, ProQuest Investments was known for its substantial capital commitments. For instance, the firm successfully raised ProQuest Investments III, a fund totaling $250 million, which underscored its capacity to deploy significant resources into its portfolio companies. Typical first-time investments from ProQuest ranged from $5 million to $15 million, reflecting their commitment to providing meaningful capital to their portfolio companies. Their portfolio included notable companies such as Amicus Therapeutics and Proteostasis Therapeutics, among others, demonstrating their breadth of engagement within the healthcare ecosystem.

However, ProQuest Investments is no longer an active investment firm and is reported to be out of business. Consequently, it is not currently making new investments or issuing first cheques. While the firm had a significant historical presence in the healthcare venture capital landscape, its operational status means that current investment parameters, including typical check sizes, are not applicable.